I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
CONFIRM: a double-blind, placebo-controlled phase III clini..:
Dean A. Fennell
;
Emma Kirkpatrick
;
Kelly Cozens
...
2381/42124. , 2018
Link:
https://figshare.com/articles/journal_contribution/CON..
RT Journal T1
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial
UL https://suche.suub.uni-bremen.de/peid=base-ftleicesterunfig:oai:figshare.com:article_10204103&Exemplar=1&LAN=DE A1 Dean A. Fennell A1 Emma Kirkpatrick A1 Kelly Cozens A1 Mavis Nye A1 Jason Lester A1 Gerard Hanna A1 Nicola Steele A1 Peter Szlosarek A1 Sarah Danson A1 Joanne Lord A1 Christian Ottensmeier A1 Daniel Barnes A1 Stephanie Hill A1 Mihalis Kalevras A1 Tom Maishman A1 Gareth Griffiths YR 2018 K1 Uncategorized K1 Anti-PD-1 K1 Intention to treat K1 Mesothelioma K1 Nivolumab K1 Overall survival K1 PD-L1 K1 Placebo K1 Quality of life K1 Randomised controlled trial JF 2381/42124 LK http://dx.doi.org/https://figshare.com/articles/journal_contribution/CONFIRM_a_double-blind_placebo-controlled_phase_III_clinical_trial_investigating_the_effect_of_nivolumab_in_patients_with_relapsed_mesothelioma_study_protocol_for_a_randomised_controlled_trial_/10204103 DO https://figshare.com/articles/journal_contribution/CONFIRM_a_double-blind_placebo-controlled_phase_III_clinical_trial_investigating_the_effect_of_nivolumab_in_patients_with_relapsed_mesothelioma_study_protocol_for_a_randomised_controlled_trial_/10204103 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)